122 related articles for article (PubMed ID: 38643542)
1. A high-dose of ursodeoxycholic acid treatment alleviates liver inflammation by remodeling gut microbiota and bile acid profile in a mouse model of non-alcoholic steatohepatitis.
Li H; Wang M; Chen P; Zhu M; Chen L
Biomed Pharmacother; 2024 May; 174():116617. PubMed ID: 38643542
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model.
Li H; Wang Q; Chen P; Zhou C; Zhang X; Chen L
Front Pharmacol; 2021; 12():788558. PubMed ID: 34938193
[TBL] [Abstract][Full Text] [Related]
3. Pure total flavonoids from citrus attenuate non-alcoholic steatohepatitis via regulating the gut microbiota and bile acid metabolism in mice.
He B; Jiang J; Shi Z; Wu L; Yan J; Chen Z; Luo M; Cui D; Xu S; Yan M; Zhang S; Chen Z
Biomed Pharmacother; 2021 Mar; 135():111183. PubMed ID: 33401222
[TBL] [Abstract][Full Text] [Related]
4. Soyasaponin A
Xiong F; Zheng Z; Xiao L; Su C; Chen J; Gu X; Tang J; Zhao Y; Luo H; Zha L
Mol Nutr Food Res; 2021 Jul; 65(14):e2100067. PubMed ID: 34047448
[TBL] [Abstract][Full Text] [Related]
5. Intermittent Fasting Alleviates Non-Alcoholic Steatohepatitis by Regulating Bile Acid Metabolism and Promoting Fecal Bile Acid Excretion in High-Fat and High-Cholesterol Diet Fed Mice.
Lin X; Zhu X; Xin Y; Zhang P; Xiao Y; He T; Guo H
Mol Nutr Food Res; 2023 Jul; 67(14):e2200595. PubMed ID: 37148502
[TBL] [Abstract][Full Text] [Related]
6. Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice.
Li Q; Li M; Li F; Zhou W; Dang Y; Zhang L; Ji G
J Ethnopharmacol; 2020 Aug; 258():112896. PubMed ID: 32325178
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice.
Kim JK; Lee KS; Lee DK; Lee SY; Chang HY; Choi J; Lee JI
Exp Mol Med; 2014 Dec; 46(12):e127. PubMed ID: 25523099
[TBL] [Abstract][Full Text] [Related]
8. Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis.
Li H; Xi Y; Xin X; Tian H; Hu Y
Biomed Pharmacother; 2020 Apr; 124():109915. PubMed ID: 31986416
[TBL] [Abstract][Full Text] [Related]
9. Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut-Liver Axis.
Yang C; Wan M; Xu D; Pan D; Xia H; Yang L; Sun G
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639207
[TBL] [Abstract][Full Text] [Related]
10. Dietary cholesterol drives the development of nonalcoholic steatohepatitis by altering gut microbiota mediated bile acid metabolism in high-fat diet fed mice.
Gao X; Lin X; Xin Y; Zhu X; Li X; Chen M; Huang Z; Guo H
J Nutr Biochem; 2023 Jul; 117():109347. PubMed ID: 37031879
[TBL] [Abstract][Full Text] [Related]
11. Integrated omics analysis unraveled the microbiome-mediated effects of Yijin-Tang on hepatosteatosis and insulin resistance in obese mouse.
Lee JE; Lee SM; Jung J
Phytomedicine; 2020 Dec; 79():153354. PubMed ID: 32992082
[TBL] [Abstract][Full Text] [Related]
12. Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet-fed mice.
Takahashi S; Luo Y; Ranjit S; Xie C; Libby AE; Orlicky DJ; Dvornikov A; Wang XX; Myakala K; Jones BA; Bhasin K; Wang D; McManaman JL; Krausz KW; Gratton E; Ir D; Robertson CE; Frank DN; Gonzalez FJ; Levi M
J Biol Chem; 2020 Apr; 295(14):4733-4747. PubMed ID: 32075905
[TBL] [Abstract][Full Text] [Related]
13. Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites.
Zhu M; Wang X; Wang K; Zhao Z; Dang Y; Ji G; Li F; Zhou W
Front Cell Infect Microbiol; 2023; 13():1066053. PubMed ID: 36779187
[TBL] [Abstract][Full Text] [Related]
14. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
[TBL] [Abstract][Full Text] [Related]
15. Stigmasterol Protects Against Steatohepatitis Induced by High-Fat and High-Cholesterol Diet in Mice by Enhancing the Alternative Bile Acid Synthesis Pathway.
Xin Y; Li X; Zhu X; Lin X; Luo M; Xiao Y; Ruan Y; Guo H
J Nutr; 2023 Jul; 153(7):1903-1914. PubMed ID: 37269906
[TBL] [Abstract][Full Text] [Related]
16. Impact of Vancomycin Treatment and Gut Microbiota on Bile Acid Metabolism and the Development of Non-Alcoholic Steatohepatitis in Mice.
Kasai K; Igarashi N; Tada Y; Kani K; Takano S; Yanagibashi T; Usui-Kawanishi F; Fujisaka S; Watanabe S; Ichimura-Shimizu M; Takatsu K; Tobe K; Tsuneyama K; Furusawa Y; Nagai Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835461
[TBL] [Abstract][Full Text] [Related]
17.
Liu L; Deng L; Wei W; Li C; Lu Y; Bai J; Li L; Zhang H; Jin N; Li C; Zhao C
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762300
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling.
Marchianò S; Biagioli M; Roselli R; Zampella A; Di Giorgio C; Bordoni M; Bellini R; Urbani G; Morretta E; Monti MC; Distrutti E; Fiorucci S
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Nov; 1867(11):159218. PubMed ID: 35985473
[TBL] [Abstract][Full Text] [Related]
19. INT-767 improves histopathological features in a diet-induced
Roth JD; Feigh M; Veidal SS; Fensholdt LK; Rigbolt KT; Hansen HH; Chen LC; Petitjean M; Friley W; Vrang N; Jelsing J; Young M
World J Gastroenterol; 2018 Jan; 24(2):195-210. PubMed ID: 29375205
[TBL] [Abstract][Full Text] [Related]
20. Calcium Reduces Liver Injury in Mice on a High-Fat Diet: Alterations in Microbial and Bile Acid Profiles.
Nadeem Aslam M; Bassis CM; Zhang L; Zaidi S; Varani J; Bergin IL
PLoS One; 2016; 11(11):e0166178. PubMed ID: 27851786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
